Survival analysis using Kaplan-Meier curves demonstrated that high mRNA expression of each PLOD gene was significantly associated with reduced OS and DFS in ccRCC patients (Figures 3A, B). This evidence concerns the gene PLOD1 and nonpapillary renal cell carcinoma.